774 related articles for article (PubMed ID: 18449026)
1. Advances in facial rejuvenation: botulinum toxin type a, hyaluronic acid dermal fillers, and combination therapies--consensus recommendations.
Carruthers JDA; Glogau RG; Blitzer A;
Plast Reconstr Surg; 2008 May; 121(5 Suppl):5S-30S. PubMed ID: 18449026
[TBL] [Abstract][Full Text] [Related]
2. Advances in facial rejuvenation: Botulinum toxin A. Hyaluronic acid dermal fillers, and combination therapies--consensus recomendations. Editor's Foreword.
Rohrich RJ
Plast Reconstr Surg; 2008 May; 121(5 Suppl):1S-2S. PubMed ID: 18449023
[No Abstract] [Full Text] [Related]
3. Global Aesthetics Consensus: Hyaluronic Acid Fillers and Botulinum Toxin Type A-Recommendations for Combined Treatment and Optimizing Outcomes in Diverse Patient Populations.
Sundaram H; Liew S; Signorini M; Vieira Braz A; Fagien S; Swift A; De Boulle KL; Raspaldo H; Trindade de Almeida AR; Monheit G;
Plast Reconstr Surg; 2016 May; 137(5):1410-1423. PubMed ID: 27119917
[TBL] [Abstract][Full Text] [Related]
4. Global Aesthetics Consensus: Botulinum Toxin Type A--Evidence-Based Review, Emerging Concepts, and Consensus Recommendations for Aesthetic Use, Including Updates on Complications.
Sundaram H; Signorini M; Liew S; Trindade de Almeida AR; Wu Y; Vieira Braz A; Fagien S; Goodman GJ; Monheit G; Raspaldo H;
Plast Reconstr Surg; 2016 Mar; 137(3):518e-529e. PubMed ID: 26910696
[TBL] [Abstract][Full Text] [Related]
5. Consensus Recommendations for Combined Aesthetic Interventions in the Face Using Botulinum Toxin, Fillers, and Energy-Based Devices.
Carruthers J; Burgess C; Day D; Fabi SG; Goldie K; Kerscher M; Nikolis A; Pavicic T; Rho NK; Rzany B; Sattler G; Sattler S; Seo K; Werschler WP; Carruthers A
Dermatol Surg; 2016 May; 42(5):586-97. PubMed ID: 27100962
[TBL] [Abstract][Full Text] [Related]
6. Hyaluronic acid filler and botulinum Neurotoxin delivered simultaneously in the same syringe for effective and convenient combination aesthetic rejuvenation therapy.
Kenner JR
J Drugs Dermatol; 2010 Sep; 9(9):1135-8. PubMed ID: 20865847
[TBL] [Abstract][Full Text] [Related]
7. Providing Optimal Rejuvenation to the Periocular Area Using Botulinum Toxin A Neuromodulators and Hyaluronic Acid Dermal Fillers.
Varga R
Plast Surg Nurs; 2019; 39(4):119-124. PubMed ID: 31790040
[TBL] [Abstract][Full Text] [Related]
8. Global 3-dimensional approach to natural rejuvenation: recommendations for perioral, nose, and ear rejuvenation.
Gassia V; Raspaldo H; Niforos FR; Michaud T
J Cosmet Dermatol; 2013 Jun; 12(2):123-36. PubMed ID: 23725306
[TBL] [Abstract][Full Text] [Related]
9. Current concepts in lip augmentation.
Mannino GN; Lipner SR
Cutis; 2016 Nov; 98(5):325-329. PubMed ID: 28040807
[TBL] [Abstract][Full Text] [Related]
10. How to achieve synergy between volume replacement and filling products for global facial rejuvenation.
Raspaldo H; Aziza R; Belhaouari L; Berros P; Body S; Galatoire O; Le Louarn C; Michaud T; Niforos F; Rousseaux I; Runge M; Taieb M
J Cosmet Laser Ther; 2011 Apr; 13(2):77-86. PubMed ID: 21401381
[TBL] [Abstract][Full Text] [Related]
11. Multicenter, randomized, parallel-group study of the safety and effectiveness of onabotulinumtoxinA and hyaluronic acid dermal fillers (24-mg/ml smooth, cohesive gel) alone and in combination for lower facial rejuvenation.
Carruthers A; Carruthers J; Monheit GD; Davis PG; Tardie G
Dermatol Surg; 2010 Dec; 36 Suppl 4():2121-34. PubMed ID: 21134044
[TBL] [Abstract][Full Text] [Related]
12. Correcting age-related changes in the face by use of injectable fillers and neurotoxins.
Rubin MG; Cox SE; Kaminer MS; Solish N
Semin Cutan Med Surg; 2014 Jun; 33(4 Suppl):S81-4. PubMed ID: 25268602
[TBL] [Abstract][Full Text] [Related]
13. Global, 3-dimensional approach to natural rejuvenation: part 1 - recommendations for volume restoration and the periocular area.
Raspaldo H; Gassia V; Niforos FR; Michaud T
J Cosmet Dermatol; 2012 Dec; 11(4):279-89. PubMed ID: 23174051
[TBL] [Abstract][Full Text] [Related]
14. Topical skin therapies in subjects undergoing full facial rejuvenation.
Dayan SH; Bacos JT; Ho TT; Gandhi ND; Gutierrez-Borst S; Kalbag A
J Cosmet Dermatol; 2019 Jun; 18(3):798-805. PubMed ID: 31033162
[TBL] [Abstract][Full Text] [Related]
15. Combined treatment for skin rejuvenation and soft-tissue augmentation of the aging face.
Beer KR
J Drugs Dermatol; 2011 Feb; 10(2):125-32. PubMed ID: 21283916
[TBL] [Abstract][Full Text] [Related]
16. Injectable treatments for the aging face.
Wise JB; Greco T
Facial Plast Surg; 2006 May; 22(2):140-6. PubMed ID: 16847805
[TBL] [Abstract][Full Text] [Related]
17. The role of hyaluronic acid fillers (Restylane) in facial cosmetic surgery: review and technical considerations.
Rohrich RJ; Ghavami A; Crosby MA
Plast Reconstr Surg; 2007 Nov; 120(6 Suppl):41S-54S. PubMed ID: 18090342
[TBL] [Abstract][Full Text] [Related]
18. Patient Satisfaction and Efficacy of Full-Facial Rejuvenation Using a Combination of Botulinum Toxin Type A and Hyaluronic Acid Filler.
Molina B; David M; Jain R; Amselem M; Ruiz-Rodriguez R; Ma MY; Kerrouche N; Georgantopoulos SP; Radeau T; Boineau D
Dermatol Surg; 2015 Dec; 41 Suppl 1():S325-32. PubMed ID: 26618460
[TBL] [Abstract][Full Text] [Related]
19. Facial Assessment and Injection Guide for Botulinum Toxin and Injectable Hyaluronic Acid Fillers: Focus on the Upper Face.
de Maio M; Swift A; Signorini M; Fagien S;
Plast Reconstr Surg; 2017 Aug; 140(2):265e-276e. PubMed ID: 28746271
[TBL] [Abstract][Full Text] [Related]
20. Rejuvenation of the Upper Face and Brow: Neuromodulators and Fillers.
Lighthall JG
Facial Plast Surg; 2018 Apr; 34(2):119-127. PubMed ID: 29631280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
